edited by
Ronald Ross Watson
AIDS and Heart Disease examines:
- recent advances in our understanding of HIV-associated endothelial injury including the expression of cytokines and adhesion molecules, apoptosis, and endothelial permeability
- clinical investigations on atherosclerosis, pulmonary hypertension, and thrombosis in HIV-infected patients
- the benefits of antioxidant vitamins in coronary heart disease (CHD) prevention using animal studies, human epidemiological research, and clinical trials
- dietary strategies to aid in the prevention of autoimmune disease and CVD
- adverse effects associated with highly active antiretroviral therapies (HAART)
- common cardiac manifestations such as myocarditis, dilated cardiomyopathy, endocarditis, pericardial effusion, arteriopathy, and cardiac malignant neoplasms
- reveals the impact of HIV on the heart and related vascular systems
AIDS and Heart Disease is the first reference to collect the latest research and reviews on the treatment and pathogenesis of heart disease in AIDS patients.
AIDS and Heart Disease attempts to improve the diagnosis, management, and therapy of HIV-associated heart failure by studying the prolonged effects of immunosuppression and opportunistic and viral infection, as well as cofactors affecting heart disease such as drug-related cardiotoxicity, cocaine abuse, and nutritional deficiencies on cardiac function.
Contents:
- Heart disease in AIDS
- Mechanisms of atherogenesis in HIV infection
- Role of HIV-1 macropinocytosis and cardiomyocyte apoptosis in the pathogenesis of HIV cardiomyopathy
- HIV-1 and the blood-brain barrier
- HIV, cocaine, and the heart : pathophysiology and clinical implications
- HIV-associated thrombotic microangiopathy
- Pathogenesis of HIV-associated vasculopathy
- Causative factors of cardiovascular complications in AIDS
- HIV-associated vascular disease and endothelial injury
- Tat-induced angiogenesis
- Nutrients as modulators of immune dysfunction and dyslipidemia in AIDS
- Antioxidant vitamins and heart disease prevention
- Nutrients and treatment of heart disease in AIDS
- Will soy protein help HIV patients with cardiovascular risk?
- N-3 fatty acid supplementation in AIDS patients with cardiac complications
- A role for dietary protein in the AIDS wasting syndrome and heart disease?
- Role of antioxidants in reducing heart disease in HIV-infected patients
- Antioxidant vitamins and antiretroviral therapy during HIV infection : effects on oxidative damage
- Vitamin E retards heart disease in AIDS patients
- HIV- and cocaine-induced subclinical atherosclerosis
- Cocaine, HIV, and heart disease : research at NIDA and recommendations for future research
- Cocaine-induced exacerbation of viral myocarditis
- Role of the catecholamine-nitric oxide system in cocaine- and HIV-induced vascular inflammation and its pharmacological implications
- Cardiovascular complications of HIV/AIDS and substance abuse
- Lipids, lipodystrophy, and AIDS
- Pathogenesis of HIV-associated cardiovascular complications in the HAART era
- Lipodystrophy syndrome and HIV disease
- The role of N-3 fatty acids in preventing coronary artery disease and arrhythmias in AIDS patients : a hypothesis
- Cardiovascular involvement in simian AIDS in nonhuman primates
- Cardiac disease in HIV-1 Tg animals
- Murine AIDS and HIV-1 dementia
Index